[The Beta2-AR is a potential prognostic biomarker for survival and tumor recurrence in HCC patients after curative resection.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE